1. Topical Vapocoolant-Associated Vaso-occlusive Event in a 10-year-old with Sickle Cell Disease
- Author
-
Matthew S. MacDougall, Alekya Kothamasu, Lewis L. Hsu, and Jocelyn Mallard
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,030504 nursing ,business.industry ,Event (relativity) ,Occlusive ,Pain ,Disease ,Anemia, Sickle Cell ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Pain Management ,030212 general & internal medicine ,0305 other medical science ,Intensive care medicine ,business ,Child ,Rare disease ,Pain Measurement - Abstract
Vapocoolant sprays are convenient forms of cold temperature analgesia. These sprays may not be suitable for all patients with particular concern for patients with sickle cell disease. To prevent any further cases from occurring, we propose adding a more specific cautionary statement to the manufacturer guidelines. We also hope that medical personnel can help patients with sickle cell avoid topical and environmental cold temperature triggers for sickle vaso-occlusive pain and reduce the suffering in this rare disease.
- Published
- 2021